Accurate diagnosis coding is an important part of billing for patients receiving care for uterine cancer. The ICD 10 code for uterine cancer depends on the documented location of the malignancy and the level of specificity supported by the medical record.
C54 Malignant tumor of corpus uteri C55 Malignant neoplasm of uterus, part unspecified ICD-10-CM has codes for the isthmus, endometrium, myometrium, fundus, overlapping sites, and nonspecific corpus uteri under C54.
Oncology & OB/GYN sites need correct diagnosis coding, extensive documentation, patient prep and procedure coding, insurance verification, auth, claim submission, payment posting and denial management. When you bill consistently, you’ll help keep you out of needless claim denials and get paid swiftly.
What Is the ICD 10 Code for Uterine Cancer?
ICD-10-CM Site Map
The documented anatomical location helps determine the appropriate uterine cancer code.
C54.0
Isthmus uteri
C54.1
Endometrium
C54.2
Myometrium
C54.3
Fundus uteri
C54.8
Overlapping sites
C54.9
Corpus unspecified
C55
Uterus, part unspecified
There is not one single code for every uterine cancer diagnosis. The appropriate uterine cancer ICD 10 code depends on the anatomical site documented by the provider.
For the official ICD-10 classification of malignant neoplasms of the corpus uteri and uterus, coders can refer to the CDC ICD-10 classification.
| ICD-10-CM Code | Description |
| C54.0 | Malignant neoplasm of isthmus uteri |
| C54.1 | Malignant neoplasm of endometrium |
| C54.2 | Malignant neoplasm of myometrium |
| C54.3 | Malignant neoplasm of fundus uteri |
| C54.8 | Malignant neoplasm of overlapping sites of corpus uteri |
| C54.9 | Malignant neoplasm of corpus uteri, unspecified |
| C55 | Malignant neoplasm of uterus, part unspecified |
These codes allow coders to report uterine malignancies according to the documented anatomical site.
C54.0: Malignant Neoplasm of Isthmus Uteri
C54.0 is malignant tumor of the isthmus uteri. The isthmus is the part of the uterus between the corpus and the cervix.
Rather than arbitrarily assigning a diagnosis code for an uncertain uterine cancer, coders should review documentation for support of C54.0.
C54.1: Malignant Neoplasm of Endometrium
C54.1 – Malignant Neoplasm of Corpus Uteri This is the primary ICD 10 code for carcinoma of the endometrium.
Endometrial tissue is the tissue that is in the most internal part of the uterus. When the supplier specifically says endometrial malignancy as opposed to the fairly general code of C54.1, coders are left to decide if this is the most effective code to apply.
C54.2: Malignant Neoplasm of Myometrium
C54.2 denotes malignant tumor of the myometrium, the muscular layer of the uterine wall.
If the provider provides documentation, the coder should review the clinical record and the ICD-10-CM codebook regulations that apply to this site before coding for this site.
C54.3: Malignant Neoplasm of Fundus Uteri
C54.3 Malignant tumor of fundus uteri (top region of the uterus)
If the tumor site is well documented, this may help the coding team to decide if this particular code is appropriate or not.
C54.8: Malignant Neoplasm of Overlapping Sites of Corpus Uteri
C54.8 is malignant tumor with overlapping sites of corpus uteri.
This code may be used when the site of the malignancy overlaps and the exact site of origin cannot be determined to a single specific site. Coders must read the documentation carefully before implementing this code.
C54.9: Malignant Neoplasm of Corpus Uteri, Unspecified
C54.9 Malignant neoplasm of corpus uteri, unclear place
If the information in the record is cancer of the corpus uteri and no site is listed, the diagnosis code C54.9 may be utilized.
But coders must review the entire record prior to using a non-specific code. In instances when the provider notes the endometrium, myometrium, fundus or isthmus, then the specific code should be considered.
C55: Malignant Neoplasm of Uterus, Part Unspecified
C55 Malignant neoplasm of uterus, portion unspecified C55.
The code applies when the medical record does not identify the exact uterine site. For C54.9, use the code for malignant neoplasm of the corpus uteri, unspecified. Do not assume C55 is C54.9. C55 Uterus, unspecified portion.
How to Choose the Right Uterine Cancer ICD 10 Code
Four Clinical Checks
Identify the condition documented by the treating provider.
Check whether the record identifies the endometrium, myometrium, fundus, isthmus, or another site.
Review relevant pathology and clinical documentation according to applicable coding rules.
Verify the ICD-10-CM code set applicable to the date of service.
To start the process of selecting the correct uterine cancer diagnosis code, you’ll need the medical record. Coders should not choose a code based solely on symptoms or treatment, but rather check the provider’s diagnosis and accompanying evidence.
1. Confirm the Documented Diagnosis
First, identify the diagnosis documented by the provider.
Information such oncology notes, pathology reports, operation reports, photos, hospital records, or follow-up notes.
If the physician reports the anomaly, uterine mass, or suspected malignancy as a cancer, confirmed cancer may not be assigned. The coding decision should follow the applicable guidelines for the encounter.
2. Identify the Anatomical Site
Next, determine whether the documentation identifies a specific uterine location.
Look for references to:
- Isthmus
- Endometrium
- Myometrium
- Fundus
- Overlapping sites
- Corpus uteri
- Uterus without a specified part
The documented site can determine whether a C54 code or C55 is appropriate.
3. Review Pathology and Clinical Documentation
Pathology and other clinical records may provide important information about the diagnosis and tumor location.
However, coders should apply the applicable ICD-10-CM rules when translating clinical documentation into diagnosis codes. If records contain conflicting or unclear information, the practice should follow its compliant documentation clarification process.
4. Verify the Current Code Set
ICD-10-CM codes and guidelines are revised throughout the year. Before billing, billing teams should confirm the code set utilized on the date of service.
Annual updates can affect diagnosis and procedure coding workflows. Practices should therefore keep their coding references and billing systems current.
For additional information about coding updates, see our Urology CPT Coding Updates 2026 article.
Uterine Cancer Coding Guidelines for Accurate Claims
Accurate uterine cancer coding depends on documentation, specificity, and proper application of ICD-10-CM guidelines.
A coder should report the diagnosis supported by the medical record rather than assume a specific site. For example, documentation stating “endometrial cancer” provides more anatomical information than a general statement of “uterine cancer.”
Similarly, C54.9 and C55 have different descriptions. C54.9 applies to malignant neoplasm of the corpus uteri, unspecified, while C55 applies to malignant neoplasm of the uterus, part unspecified.
The practice should also confirm that the claim diagnostic is consistent with the service. Your cancer experience may include surgery, chemotherapy, radiation therapy, imaging, laboratory and pathology services, and consultations and follow-up.
Each service should be coded according to the documentation and applicable payer requirements.
Common Uterine Cancer ICD 10 Coding Errors
Watch for These Coding Problems
Specific Site Overlooked
A documented uterine site should be reviewed before selecting a broad unspecified code.
Unconfirmed Cancer
A mass or suspected tumor does not automatically establish a confirmed malignant diagnosis.
Outdated References
Coding references and systems should reflect the requirements applicable to the service date.
Missing Documentation
Incomplete records can make it difficult to support a specific diagnosis and medical necessity.
Coding problems can occur when practices use broad codes, overlook documentation, or rely on outdated coding information.
Using C55 When the Uterine Site Is Documented
A common issue is selecting C55 when the record identifies a specific uterine site.
For example, documentation identifying the endometrium may support review of C54.1 rather than automatically using C55.
The goal is to select the most specific code supported by the documentation and applicable coding guidelines.
Confusing C54.9 and C55
C54.9 and C55 should not be treated as identical.
C54.9 represents malignant neoplasm of a corpus uteri, unspecified.
Understanding this distinction can help reduce diagnosis coding errors and improve claim accuracy.
Coding a Suspected Tumor as Confirmed Cancer
Each and every coding condition does not automatically confirm malignant neoplasm for a uterine tumor or aberrant imaging result.
Coders must study the documentation of the provider and follow the applicable criteria for the particular healthcare environment and encounter.
Using Outdated Code Information
ICD-10-CM resources were updating annually. Using outdated code of tables, software, or reference materials can lead to be inaccurate claims.
Regular coding education and internal audits can help practices identify outdated information before it affects multiple claims.
Failing to Review Supporting Documentation
The diagnosis should be supported by the patient’s medical record.
If documentation does not clearly identify a location or diagnosis, the coding team didn’t have enough information to select the specific code.
For another example of how documentation and coding details can affect claims, see our Wound Care ICD-10 guide.
Confusing Primary and Secondary Malignancy
Cancer patients may have complex medical histories involving multiple malignant sites.
The coding team should review the record carefully when documentation mentions previous cancers, metastatic disease, or multiple treatment locations. The diagnosis should reflect the condition supported by the documentation and applicable coding guidelines.
Uterine Cancer Documentation Requirements
Strong documentation gives coding teams the information needed to assign an accurate diagnosis code.
The National Cancer Institute provides additional information on uterine cancers, including endometrial cancer and uterine sarcoma.
For uterine cancer encounters, documentation may include:
- Confirmed diagnosis
- Anatomical site
- Pathology findings
- Clinical assessment
- Treatment plan
- Surgical history
- Relevant imaging findings
- Follow-up information
- Medical necessity for services
For example, “uterine cancer” provides less information than “malignant neoplasm of endometrium.” When a specific site is known and documented, that information can support more precise coding.
Documentation also affects the medical billing process. When a payer reviews a claim, the medical record may need to demonstrate why the service was performed and how it relates to the patient’s condition.
How Uterine Cancer Coding Affects Medical Billing
The diagnosis code is an important part of the medical claim, but reimbursement depends on the complete billing process.
For uterine and endometrial cancer patients, practices may manage multiple services during diagnosis, treatment, and follow-up. The revenue cycle can involve:
- Diagnosis coding
- Procedure coding
- Insurance verification
- Prior authorization
- Claim submission
- Medical necessity review
- Payment posting
- Accounts receivable follow-up
- Denial management
- Appeals
Professional medical billing services can help practices coordinate these functions and maintain a consistent revenue cycle.
Minnesota Billing Services provides billing support that includes medical billing, coding, eligibility verification, authorization, accounts receivable follow-up, and revenue cycle services.
Uterine Cancer Billing Challenges for Oncology and OB/GYN Practices
Cancer billing can become complicated when patients receive multiple services over an extended period.
Oncology and OB/GYN practices may need to manage diagnosis coding, procedures, treatment-related claims, payer requirements, authorizations, and documentation.
Minnesota Billing Services provides specialty-focused billing support for areas including oncology billing and OB/GYN billing.
A strong workflow should connect clinical documentation with coding and then connect coding with claim submission and follow-up. This makes it easier to identify where a claim problem originates.
Denial Prevention for Uterine Cancer Claims
Denial prevention should begin before a claim reaches the payer.
For uterine cancer claims, practices can review:
- Patient eligibility
- Authorization requirements
- Provider documentation
- ICD-10 diagnosis coding
- CPT and HCPCS coding
- Modifier requirements
- Payer-specific requirements
- Timely filing requirements
When documentation identifies a specific portion of the uterus, it is categorized to the level of specificity.
If a claim is rejected, don’t re-submit the same information. When a claim keeps getting denied, find the underlying reason. Repeated denials relating to a diagnosis may be due to coding or paperwork difficulties.
Repeated authorization denials can be as simple as not having pre-service approval. A denial management services can work to categories denials, find common causes, fix claims, administer appeals and analyses payer behavior.
Why Specialized Oncology Billing Services Matter
Oncology billing is a process that involves filing claims. It may include the management of documentation, diagnosis coding, procedures, authorizations, payer standards and norms, and ongoing follow-up.
Specialized oncology medical billing services can support these administrative functions while clinical teams focus on patient care.
Uterine Cancer Coding teams should be knowledgeable with the distinction between C54 and C55 when referring to a uterine cancer and know when the clinical material supports a more precise code.
The billing partner can also assist with insurance verification, claims submission, AR collection, denials handling and reporting.
Uterine Cancer Coding and Revenue Cycle Management
Uterine cancer coding should work as part of the overall revenue cycle rather than as a separate task.
The process begins with provider documentation. The coding team reviews the record and assigns the applicable ICD-10-CM and procedure codes. The billing team then reviews the claim before submission.
After submission, the claim should be monitored through payer processing.
The billing team posts the payment upon receipt and makes modifications as required. If a claim is denied or rejected, the billing team should analyses the payer’s justification for the rejection or denial, remedy the error if possible and submit a resubmission or appeal.
This comprehensive strategy can be helpful in oncology practices that offer continuing therapy and follow-up care.
When Should a Practice Consider Outsourcing Uterine Cancer Billing?
A practice may be consider outsourcing when it is the internal team difficulty keeping up with a claim volume, coding requirements, AR follow-up, denials, or payer processes.
Outsourcing can provide access to professional medical billing services without requiring the practice to manage every revenue cycle function internally.
Before choosing a medical billing company for oncology practices, providers should evaluate the company’s experience with:
A billing partner may also provide credentialing services to help practices manage provider enrollment and payer-related administrative requirements.
- ICD-10-CM coding
- Oncology billing
- OB/GYN billing
- Claim submission
- Insurance verification
- Prior authorization
- Denial management
- AR follow-up
- Documentation review
- Revenue cycle management
Minnesota Billing Services provides medical coding support and describes its coding services as covering ICD-10, CPT, HCPCS, professional fee coding, facility coding, payer-specific coding, and documentation feedback.
How Medical Coding Services Support Uterine Cancer Billing
Professional medical coding services can assist clinics convert clinical paperwork into appropriate diagnostic and procedure codes.
For uterine cancer this includes if the documentation supports C54.0, C54.1, C54.2, C54.3, C54.8, C54.9 or C55.
The coding team also must keep up to speed on the annual ICD-10-CM modifications and utilize the right set of codes for the date of service.
Develop a uniform billing process by implementing coding and eligibility verification, authorization, claim review and rejection follow-up.
Uterine Cancer Reimbursement: What Practices Should Review
From Documentation to Reimbursement
Clinical Documentation
The provider documents the diagnosis, site, treatment, and relevant clinical information.
Coding & Claim Preparation
Diagnosis and procedure information is reviewed before the claim is submitted.
Payer Submission
The completed claim moves through payer processing and applicable review requirements.
Payment Posting
Payer payments and adjustments are posted to the appropriate account.
Denial & AR Follow-Up
Rejections, denials, outstanding balances, and appeals are reviewed and followed up.
Reimbursement depends on more than the diagnosis code. The complete claim must accurately represent the services provided and meet applicable payer requirements.
Practices should review several areas when evaluating reimbursement issues.
Diagnosis-to-Procedure Relationship
The diagnosis should accurately represent the documented condition and support the medical necessity of the services billed.
Documentation Support
Clinical documentation should contain enough information to support the diagnosis and services reported on the claim.
Payer Requirements
Payers may have specific requirements related to authorization, medical necessity, claim submission, or supporting documentation.
Denial and Underpayment Monitoring
Practices should monitor both denied and underpaid claims. Looking only at complete denials can allow other reimbursement problems to remain unnoticed.
Accounts Receivable Follow-Up
Unpaid claims should be monitored according to payer timelines so that follow-up occurs before filing or appeal deadlines expire.
An effective oncology revenue cycle management process brings these activities together to support more consistent financial operations.
Final Thoughts
The ICD 10 code for uterine cancer is determined by the location of the malignancy as stated in the medical record. The C54 category encompasses malignant neoplasms of the corpus uteri, including neoplasms of the endometrium, myometrium, fundus, isthmus, overlapping sites and corpus uteri, unspecified. C55 Malignant tumor of uterus, unspecified portion. C55 is malignant neoplasm of uterus, unspecified part.
Accurate coding is only one part of successful cancer billing. Complete documentation, appropriate An effective revenue cycle includes billing and coding, insurance eligibility and verification, prior auth, claim submission, payment posting, AR collection and denial management.
Practices providing care for uterine cancer or endometrial cancer or other oncology services, a consistent billing and coding process may assist minimize avoidable claim rejections and assure getting paid immediately.
Minnesota Billing Services provides billing and coding solutions for healthcare practices, if your practice requires support with uterine cancer coding, oncology billing, medical coding, or revenue cycle management.
Frequently Asked Questions
What is the ICD 10 code for uterine cancer?
The ICD-10-CM code depends on the documented uterine site. C54 includes malignant neoplasms of the corpus uteri, while C55 represents malignant neoplasm of the uterus, part unspecified.
What is the ICD 10 code C54.1?
C54.1 is the ICD-10-CM code for malignant neoplasm of the endometrium. It is commonly associated with endometrial cancer ICD 10 coding.
What is the ICD 10 code C54.9?
C54.9 represents malignant neoplasm of the corpus uteri, unspecified. It applies when the record establishes malignant neoplasm of the corpus uteri but does not identify the particular site.
What is the ICD 10 code C55?
C55 represents malignant neoplasm of the uterus, part unspecified. It is different from C54.9, which refers specifically to the unspecified site of the corpus uteri.
Is uterine cancer the same as endometrial cancer for ICD-10 coding?
Not necessarily. Uterine cancer is a broader term, while endometrial cancer identifies a malignancy of the endometrium. The appropriate code should reflect the condition and anatomical site documented by the provider.